The administration of C, an a adrenergic agonist, induces GH s e c r e t i o n , sedation and hypotenszon.
s e c r e t i o n , sedation and hypotenszon.
To t e s t the hypothesis t h a t these e f f e c t s a r e independent of one another, we measured GH responses t o o r a l C (4 ug/kg) i n 14 SS p a t i e n t s whose post-exerc i s e GH was <7 ng/ml and i n 5 TS patients. Plasma C l e v e l s , blood pressure and degree of sedation were recorded a s were plasma l e v e l s of 3-methoxy-4 hydroxyphenyl glycol (MHPG). To determine the persistence of GH responsiveness the 5 TS were restudied a f t e r 3 mos Rx with C.
GH peaks (mean 17.4'3 ng/ml) occurred a t 60-90 min. i n a l l TS and 9/14 SS p a t i e n t s . There was no tendency f o r responsiveness t o diminish a f t e r Rx with C with mean post Rx GH peaks of 22+5 ng/ml i n the 5 TS. I n 5/14 SS, a l l GH d e f i c i e n t on i n s u l i n testing, peak GH was (3 ng/ml. C l e v e l s rose t o a peak of 1.2'3 ng/ml a t 60'. preceding the GH peak by 30'. An observed 12% f a l l i n MHPG l e v e l s ( a t t r i b u t a b l e t o a C-mediated reduction i n c e n t r a l nervous system (CNS) noradrenergic a c t i v i t y ) was not rel a t e d t o the timing o r e x t e n t of the GH peaks. These peaks a l s o bore l i t t l e temporal r e l a t i o n s h i p t o the s l i g h t hypotension o r marked sedation occurring a f t e r o r a l C. W e conclude t h a t C is a highly e f f e c t i v e t o o l f o r the diagnosis of GH deficiency and t h a t the GH response t o C is sustained during chronic Rx with C. Our d a t a support animal s t u d i e s which suggest t h a t C e x e r t s i t s various e f f e c t s a t multiple s i t e s i n the CNS.
CONTINUOUS SUBCUTANEOUS INFUSION OF GROWTH HORMONE (CSIGH) I N GROWTH HORMONE DEFIC1ENCY:FEASIBILITY AND
408 SHORT TERM mTAB0LIC EFFECTS. J.Gertner , S .Page and W.Tamborlane, Dept. Ped., Yale U. School ~e-aven, CT I n c o n t r a s t t o the sustained acceleration of growth observed i n p i t u i t a r y hypersecretion of GH, f u l l catch-up growth i s rarely a t t a i n e d i n GH deficiency with conventional GH Rx (0.1 U/kg I M 3xIwk). Since c i r c u l a t i n g GH l e v e l s a r e very low f o r a l l but 24-30 h r per wk during conventional Rx, we examined t h e f e a s ib i l i t y and s h o r t term metabolic e f f e c t s of CSIGH using a small infusion pump. Fasting l e v e l s of glucose (G), i n s u l i n ( I ) , f r e e f a t t y a c i d s (FFA) and o r a l glucose tolerance were determined i n 5 previously untreated d e f i c i e n t children before and a f t e r 85 h r s of CSIGH (dose 2.1 uU/kg/hr % 0.3 U/kg/wk) .
CSIGH maintained serum GH l e v e l s a t 3-9 ng/ml during the infusion. As shown i n the t a b l e , CSIGH produced a modest increase i n f a s t i n g (0 min) G and I. Furthermore, glucose tolerance was impaired d e s p i t e 2-fold higher I l e v e l s (*p<0.05).
Plasma G: 0 min 60 min 90 min I: 0 min 60 min 90 min Pre-CSIGH 82'9 123'11 105'9 15' 4 65+11 64'6 Post-CSIGH 97'10 153+11* 143+16* 27' 6 133+23* 139'27* FFA rose sharply a f t e r 12 h r CSIGH (1021f151 vs 605'87 PM, p=0.05) but l a t e r returned t o b a s e l i n e , v a l u e s . CSIGH was well t o l e r a t e d by a l l p a t i e n t s . Conclusions: CSIGH i n standard doses produces sustained increases i n GH l e v e l s s u f f i c i e n t t o a l t e r l i p i d and carbohydrate metabolism and induce hyperinsulinemia. CSIGH might be an e f f e c t i v e a l t e r n a t e approach t o GH replacement therapy.
CAN MENTAL RETARDATIOX BE COMPLETELY OVERCOME I N CON-409 GENITAL HYPOTHYROIDISM' ( J . Glorieux, J . L e t a r t e , J.H. Dussault, H. Guyda, J.Morissette. Departments of P e d i a t r i c s , Univ. of Montreal and McGill Univ., Montreal, and Department of Medicine, Lava1 Univ., Quebec, Canada.
Congenital hypothyroidism hampers the normal growth of body and mind. I n i t i a t i o n of therapy during t h e f i r s t 3 months of l i f e i s t h e most c r i t i c a l aspect i n t h i s disease. This finding has been declsive i n t h e establishment of screening programs f o r neon a t a l hypothyroidism. Since 1974, t h e Quebec Network f o r Genetic Medicine has detected over 130 such cases. Their mental development has been assessed a t 12, 18, and 36 months. The G r i f f i t h s Mental Scales of Development were s e l e c t e d a s t h e b e s t c l i n i c a l i n d i c e s f o r developmental evaluation because t h e i r 5 d i f f e r e n t s c a l e s a r e equally weighted a t each age l e v e l . Comparison between hypothyroid children and controls has produced t h e following r e s u l t s . At 12 months: Hypos do not d i f f e r from c o n t r o l s . However, mean DQ f o r both groups i s systematically above theoret i c a l mean of 100 (114 and 113). A t 18 months: Hypos gave lower r e s u l t s than c o n t r o l s i n a l l s c a l e s , namely: locomotion, pers o n a l and s o c i a l development, hand-eye coordination, hearing and speech, and performance. l ' e r e s u l t s i n t h e l a s t two s c a l e s a s well a s f o r t h e t o t a l DQ were s t a t i s t i c a l l y d i f f e r e n t (p < 0.01)1
At 36 months: The p a t i e n t s maintained t h e same p r o f i l e noted a t 18 months. CONCLUSION: While t h e i n t e l l e c t u a l performance of hypothyroid babies is g r e a t l y improved by e a r l y treatment i n l i f e , t h i s does not produce a t o t a l l y normal mental development. This s i t u a t i o n i s already apparent a t 18 months.
EVIDENCE FOR TONIC GAMMA-AMINOBUTYRIC ACID (GABA) MEDIATED INHIBITION OF GROWTH HORMONE (GH) SECRETION
410 I N THE OVINE FETUS. Peter D. Gluckman (sponsored by M.M.Grumbach),Dept of Paediatrics,University of Auckland, Auckland, New Zealand. Circulating GH concentrations a r e high i n t h e f e t u s and f a l l a f t e r b i r t h . The high f e t a l G H l e v e l s have been postulated t o r e f l e c t immaturity of hypothalamic c o n t r o l of GH secretion. GABA mediated regulation of G H r e l e a s e was studied i n chronically c a t h e t e r i z e d ovine f e t u s e s (term 147 days) and i n f a n t lambs. Muscimol (MUSC),a GABA agonist (300ug/kg) was given i v t o 3 f e t u s e s (108-137 days) and GH f e l l from 123.6 f 53ng/mlto 64.7 f 25.7ng/ml (p (0.05). I n 2 younger f e t u s e s (95,99days) no suppression was noted. Picrotoxin, (PIC) , a GABA antagonist (500ug/kg) was given i v t o 7 fetuse s (80 -140 days) . Plasma G H rose from 76.3 f 15.6ng/ml t o 115.0 f 8.5 ng/ml (p (0.05). The incremental GH response t o PIC rose with g e s t a t i o n a l age (r=0.80, p <0.05). I n 3 neonates, GH rose following PIC from 10.6 f 8.5 ng/ml t o 45.0 f 13.9 ng/ml. Pretreatment with MUSC reduced t h e neonatal response t o PIC (n=3) i n d i c a t i n g t h a t t h e a c t i o n of PIC is mediated by GABA receptors. These d a t a a r e evidence f o r GABA receptors i n t h e f e t a l hypothalamic-pituitary u n i t . The GH response t o PIC i s evidence f o r t o n i c GABA mediated i n h i b i t i o n of f e t a l GH r e l e a s e i n t h e l a t e g e s t a t i o n f e t u s and neonate. This suggests t h a t t h e high f e t a l G H l e v e l s do not represent e n t i r e l y unrestrained a c t i v i t y of t h e hypothalamic-pituitary u n i t b u t t h a t t h e r e is p a r t i a l r e s t r a i n t of GH r e l e a s e mediated by GABA. Supported by t h e Medical Research Council of New Zealand.
Departments of Pediatrics and Psychiatry, Syracuse, New York.
To determine i f children with growth r e t a r d a t i o n a r e a t greater risk f o r academic and emotional problems than those of normal s t a t u r e , we studied twenty-five children of normal i n t e l l igence
w i t h c o n s t i t u t i o n a l s h o r t s t a t u r e o r growth hormone deficiency.
On the Child Behavior Checklist, 44% of t h e s e children scored i n the 90th p e r c e n t i l e o r higher on the overall index of behavioral d i f f i c u l t y , a level typical of children r e f e r r e d f o r mental health s e r v i c e s . Our p a t i e n t s had s p e c i f i c elevations on indices of somatic complaints, schizoidal tendencies, obsessivecompulsive t r a i t s and depression. They a l s o had a disproportiona t e incidence of excessive clowning (45%), being teased (65%), unhappiness (48%), and underachievement (41%). Another s t r i k i n g finding was t h a t the children had a high prevalence of grade r e t e n t i o n , 28% having repeated a t l e a s t one grade, i n s p i t e of having normal i n t e l l i g e n c e (mean f u l l s c a l e IQ=105.3, S.D. 1 4 . 9 ) .
Furthermore, 30% of t h e subjects had a verbal IQ t h a t was 20 o r more points higher than t h e performance score, a discrepancy occurring i n only 10% of t h e population. In conclusion, s h o r t children seem t o be a t increased r i s k f o r developing academic and emotional d i f f i c u l t i e s . To b e t t e r d e f i n e t h e development problems unioue t o these children. we a r e now administering an extensive batieky .of i n t e l l igence,-achievement, and personaii t y t e s t s t o our a t i e n t s an a control group matched f o r age, sex and socigeconomlc c f a s s . Triiodothyronine (T3) is known to induce gluwneogenesis i n t h e l i v e r o f a d u l t r a t s . Hence we enquired whether it could b e involved i n the s t e e p rise of phosphoenolpyruvate c a b x y k i n a s e (PEP&) a c t i v i t y described f o r t h e newborn. 'ItYo i n j e c t i o n s o f T3 (20 l.rg/100 g body weight each) to t h e m t h e r r a t on days 20 and 21 o f pregnancy r e s u l t e d in a ten to 50-fold r i s e in PEP& a c t iv i t y i n f e t a l liver. At t h e same time t h e r e l a t i v e l y high a c t iv i t y in brown f a t w a s decreased by about 50%. T3 l e v e l s in t h e f e t u s e s o f injected mthers were 42.75 f 2.25 ng/ml, compared t o 27.3 ? 1.8 in the c o n t r o l fetuses. I n s u c k l i n g r a t s 24 hours a f t e r a s i n g l e i n j e c t i o n o f 50ug/100 g body weight e s s e n t i a l l y the same e f f e c t s i n both t i s s u e s were observed. At t h a t time blood l e v e l s o f i n s u l i n and glucagon were k u n d t o be elevated. 103: 1417-1424, 1978) . However, T3 does n o t l e a d to a rise i n f a t t y a c i d synthetase a c t i v i t y in b r m f a t , while prednisolone does. Thus t h e mechanism o f a c t i o n o f t h e two h o m n e s a r e probably n o t t h e same. Our d a t a indicate t h a t T3 may b e involved i n t h e neonatal rise in h e p a t i c PEP& a c t i v i t y .
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